Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Nanosci Nanotechnol ; 16(6): 6327-31, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27427712

RESUMEN

End-shape-controlled gold nanorods (GNRs) were synthesized at room-temperature by a seeded-growth method, in which hexadecyltrimethylammonium bromide (CTAB) was used as a stabilizer and capping agent. The average dimension of the GNRs was 46 nm in length and 15 nm in diameter, which corresponds to aspect ratio of c.a. 3.0. Then, their both ends were further grown at the presence of silver precursor (AgNO3), resulting in formation of arrow-head GNRs. By tuning the amount of the silver precursor, the end-shape of the GNRs was changed to dumbbell like shape. Moreover, the growth rate of gold could be controlled by tuning the amount of hydrochloric acid (HCl). While arrow-headed GNRs having sharp edges were produced without HCl, the GNRs having dog-bone like or round-head shape at both ends were obtained with HCl.

2.
J Med Food ; 18(12): 1380-6, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26331671

RESUMEN

Ursolic acid is a lipophilic pentacyclic triterpenoid found in many fruits and herbs and is used in several herbal folk medicines for diabetes. In this study, we evaluated the effects of apple pomace extract (APE; ursolic acid content, 183 mg/g) on skeletal muscle atrophy. To examine APE therapeutic potential in muscle atrophy, we investigated APE effects on the expression of biomarkers associated with muscle atrophy and hypertrophy. We found that APE inhibited atrophy, while inducing hypertrophy in C2C12 myotubes by decreasing the expression of atrophy-related genes and increasing the expression of hypertrophy-associated genes. The in vivo experiments using mice fed a diet with or without APE showed that APE intake increased skeletal muscle mass, as well as grip strength and exercise capacity. In addition, APE significantly improved endurance in the mice, as evidenced by increased exhaustive running time and muscle weight, and reduced the expression of the genes involved in the development of muscle atrophy. APE also decreased the concentration of serum lactate and lactate dehydrogenase, inorganic phosphate, and creatinine, the indicators of accumulated fatigue and exercise-induced stress. These results suggest that APE may be useful as an ergogenic functional food or dietary supplement.


Asunto(s)
Malus/química , Fuerza Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Atrofia Muscular/prevención & control , Resistencia Física/efectos de los fármacos , Carrera/fisiología , Triterpenos/farmacología , Animales , Biomarcadores/sangre , Línea Celular , Suplementos Dietéticos , Tolerancia al Ejercicio , Fatiga/sangre , Fatiga/prevención & control , Frutas/química , Expresión Génica/efectos de los fármacos , Hipertrofia , Masculino , Ratones Endogámicos C57BL , Fibras Musculares Esqueléticas/efectos de los fármacos , Fuerza Muscular/genética , Músculo Esquelético/citología , Músculo Esquelético/fisiología , Atrofia Muscular/sangre , Atrofia Muscular/genética , Resistencia Física/fisiología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Triterpenos/uso terapéutico , Ácido Ursólico
3.
J Microbiol Biotechnol ; 24(12): 1736-43, 2014 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-25179898

RESUMEN

In this study, we evaluated the effect of Lactobacillus plantarum HY7714 on skin hydration in human dermal fibroblasts and in hairless mice. In Hs68 cells, L. plantarum HY7714 not only increased the serine palmitoyltransferase (SPT) mRNA level, but also decreased the ceramidase mRNA level. In order to confirm the hydrating effects of L. plantarum HY7714 in vivo, we orally administered vehicle or L. plantarum HY7714 at a dose of 1 × 10(9) CFU/day to hairless mice for 8 weeks. In hairless mice, L. plantarum HY7714 decreased UVB-induced epidermal thickness. In addition, we found that L. plantarum HY7714 administration suppressed the increase in transepidermal water loss and decrease in skin hydration, which reflects barrier function fluctuations following UV irradiation. In particular, L. plantarum HY7714 administration increased the ceramide level compared with that in the UVB group. In the experiment on SPT and ceramidase mRNA expressions, L. plantarum HY7714 administration improved the reduction in SPT mRNA levels and suppressed the increase in ceramidase mRNA levels caused by UVB in the hairless mice skins. Collectively, these results suggest that L. plantarum HY7714 can be a potential candidate for preserving skin hydration levels against UV irradiation.


Asunto(s)
Lactobacillus plantarum/crecimiento & desarrollo , Probióticos/administración & dosificación , Fenómenos Fisiológicos de la Piel/efectos de la radiación , Piel/efectos de la radiación , Rayos Ultravioleta , Administración Oral , Animales , Línea Celular , Ceramidasas/biosíntesis , Fibroblastos/fisiología , Perfilación de la Expresión Génica , Humanos , Ratones Pelados , ARN Mensajero/análisis , ARN Mensajero/genética , Serina C-Palmitoiltransferasa/biosíntesis , Piel/enzimología
4.
Biochem Biophys Res Commun ; 407(1): 175-80, 2011 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-21371429

RESUMEN

Human PTEN (phosphatase and tensin homolog deleted on chromosome 10; a phosphatidylinositol 3-phosphatase) expressed in Saccharomyces cerevisiae was oxidized in a time- and H(2)O(2)-concentration-dependent manner. Oxidized hPTEN was reduced by cellular reductants as in human cells. The reduction rate of oxidized hPTEN was monitored in S. cerevisiae mutants in which the genes involved in redox homeostasis had been disrupted. Reduction of hPTEN was delayed in each of S. cerevisiae grx5Δ and ycp4Δ mutants. Expression of Grx5 and Ycp4 in each of the mutants rescued the reduction rate of oxidized hPTEN. Furthermore, an in vitro assay revealed that the human Grx5/GSH system efficiently catalyzed the reduction of oxidized hPTEN. These results suggest that the reduction of oxidized hPTEN is regulated by Grx5 and Ycp4.


Asunto(s)
Flavodoxina/metabolismo , Glutarredoxinas/metabolismo , Fosfohidrolasa PTEN/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Secuencia de Aminoácidos , Glutarredoxinas/genética , Humanos , Peróxido de Hidrógeno/metabolismo , Datos de Secuencia Molecular , Oxidación-Reducción , Fosfohidrolasa PTEN/genética , Saccharomyces cerevisiae/genética
5.
FEBS Lett ; 584(16): 3550-6, 2010 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-20637195

RESUMEN

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expressed in Saccharomyces cerevisiae was reversibly oxidized by hydrogen peroxide and reduced by cellular reductants. Reduction of hPTEN was delayed in each of S. cerevisiae gsh1Delta and gsh2Delta mutants. Expression of gamma-glutamylcysteine synthetase Gsh1 in the gsh1Delta mutant rescued regeneration rate of hPTEN. Oxidized hPTEN was reduced by glutathione in a concentration- and time-dependent manner. Glutathionylated PTEN was detected. Incubation of 293T cells with BSO and knockdown expression of GCLc in HeLa cells by siRNA resulted in the delay of reduction of oxidized PTEN. Also, in HeLa cells transfected with GCLc siRNA, stimulation with epidermal growth factor resulted in the increase of oxidized PTEN and phosphorylation of Akt. These results suggest that the reduction of oxidized hPTEN is mediated by glutathione.


Asunto(s)
Glutatión/metabolismo , Fosfohidrolasa PTEN/metabolismo , Secuencia de Bases , Línea Celular , Cartilla de ADN/genética , Glutamato-Cisteína Ligasa/antagonistas & inhibidores , Glutamato-Cisteína Ligasa/genética , Glutamato-Cisteína Ligasa/metabolismo , Glutatión Sintasa/genética , Glutatión Sintasa/metabolismo , Células HeLa , Humanos , Técnicas In Vitro , Modelos Biológicos , Mutación , Oxidación-Reducción , Fosfohidrolasa PTEN/genética , ARN Interferente Pequeño/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo
6.
Mol Cells ; 27(5): 539-46, 2009 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-19466602

RESUMEN

In Saccharomyces cerevisiae, ribosomal protein L7, one of the approximately 46 ribosomal proteins of the 60S subunit, is encoded by paralogous RPL7A and RPL7B genes. The amino acid sequence identity between Rpl7a and Rpl7b is 97 percent; they differ by only 5 amino acid residues. Interestingly, despite the high sequence homology, Rpl7b is detected in both the cytoplasm and the nucleolus, whereas Rpl7a is detected exclusively in the cytoplasm. A site-directed mutagenesis experiment revealed that the change in the amino acid sequence of Rpl7b does not influence its sub-cellular localization. In addition, introns of RPL7A and RPL7B did not affect the subcellular localization of Rpl7a and Rpl7b. Remarkably, Rpl7b was detected exclusively in the cytoplasm in rpl7a knockout mutant, and overexpression of Rpl7a resulted in its accumulation in the nucleolus, indicating that the subcellular localization of Rpl7a and Rpl7b is influenced by the intracellular level of Rpl7a. Rpl7b showed a wide range of localization patterns, from exclusively cytoplasmic to exclusively nucleolar, in knock-out mutants for some rRNA-processing factors, nuclear pore proteins, and large ribosomal subunit assembly factors. Rpl7a, however, was detected exclusively in the cytoplasm in these mutants. Taken together, these results suggest that although Rpl7a and Rpl7b are paralogous and functionally replaceable with each other, their precise physiological roles may not be identical.


Asunto(s)
Núcleo Celular/metabolismo , Citoplasma/metabolismo , Proteínas Ribosómicas/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Schizosaccharomyces pombe/metabolismo , Transporte Activo de Núcleo Celular , Secuencia de Aminoácidos , Células Cultivadas , Perfilación de la Expresión Génica , Técnicas de Inactivación de Genes , Intrones/genética , Mutagénesis Sitio-Dirigida , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismo , Proteínas Ribosómicas/genética , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Schizosaccharomyces pombe/genética , Relación Estructura-Actividad
7.
Arch Pharm Res ; 31(11): 1517-23, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19023550

RESUMEN

This study examined the effects of ketorolac tromethamine (KT) and baicalein (BE) on the levels of inflammatory factors in human synoviocytes. The fibroblast-like synoviocytes (FLS) cells were used to determine the possible regulatory effects of KT and BE (KTBE) on the levels of inflammatory factors in FLS cells. In addition, the levels of TNF-alpha, IL-6, and IL-1beta mRNA expression in FLS cells induced by a TNF-alpha and IL-1beta co-treatment were largely inhibited by a KTBE treatment. The level of FLS cells proliferation was increased by IL-1beta and TNF-alpha, and strongly inhibited by KTBE treatment. The production of oxygen species (ROS) was inhibited by KTBE in FLS cells. KTBE appears to regulate the levels of mRNA that are important for regulating RA progression.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Flavanonas/farmacología , Mediadores de Inflamación/metabolismo , Ketorolaco Trometamina/farmacología , Antagonistas de Prostaglandina/farmacología , Líquido Sinovial/metabolismo , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Humanos , Interleucina-1beta/biosíntesis , Interleucina-6/biosíntesis , ARN Mensajero/biosíntesis , ARN Mensajero/aislamiento & purificación , Especies Reactivas de Oxígeno/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Espectrometría de Fluorescencia , Líquido Sinovial/citología , Líquido Sinovial/efectos de los fármacos , Factor de Necrosis Tumoral alfa/biosíntesis
8.
Arch Pharm Res ; 31(4): 511-7, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18449510

RESUMEN

The aim of this study was to determine if a ketorolac tromethamine (KT) gel solution could be administered in vivo via phonophoretic transdermal delivery using pulsed ultrasound by examining its anti-hyperalgesic and anti-inflammatory effects in a rat carrageenan inflammation model. 1% carrageenan was injected into the plantar surface of the right hindpaw of a rat, and anti-hyperalgesic and anti-inflammatory effects of KT via phonophoretic transdermal delivery were examined. The changes in the mechanical and thermal hyperalgesia, nociceptive flexor reflex (NFR), as well as the swelling changes were determined. According to the anti-hyperagesia and anti-inflammation tests, which were used to determine the change in the pain threshold, NFR and swelling showed that the group given the phonophoretic transdermal delivery of KT exhibited significantly more noticeable anti-hyperalgesic and anti-inflammatory effects than those treated with the simple application of a KT gel. The transdermal application of KT gel using phonophoresis had significant anti-hyperalgesic and anti-inflammatory effects. These findings suggest that the transdermal administration of a KT gel using phonophoresis using pulsed ultrasound might be useful for treating acute inflammation and pain.


Asunto(s)
Analgésicos/administración & dosificación , Antiinflamatorios/administración & dosificación , Edema/prevención & control , Hiperalgesia/prevención & control , Ketorolaco Trometamina/administración & dosificación , Umbral del Dolor/efectos de los fármacos , Fonoforesis , Administración Cutánea , Animales , Carragenina , Modelos Animales de Enfermedad , Edema/inducido químicamente , Edema/fisiopatología , Geles , Hiperalgesia/inducido químicamente , Hiperalgesia/fisiopatología , Masculino , Dimensión del Dolor , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Reflejo/efectos de los fármacos , Factores de Tiempo
9.
Arch Pharm Res ; 30(7): 871-5, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17703740

RESUMEN

Ketorolac tromethamine gel (KT gel) and ketorolac tromethamine gel containing genipin (KTG gel) were prepared and their therapeutic effects on periodontitis were evaluated. The skin permeation rate of ketorolac from the KT gel and KTG gel was 5.75+/-0.53 and 5.82 +/- 0.74 microg/cm2/ h, respectively. The skin permeation rate of genipin from the KTG gel was 10.13 +/- 1.47 microg/ cm2/h. The tensile strength of the KTG gel was larger than the KT gel. After 4 weeks, the periodontal pocket depth of the KTG gel group (3.22 +/- 0.20 mm) significantly decreased compared with the non-treated group (4.50 +/- 0.25 mm) and the KT group (3.84 +/- 00.26 mm). The KTG gel did not induce separation of the stratum corneum and subcutaneous tissue, and the collagen layers of the corium were closer, more fibrous, and showed longer connections than in the other groups. The KTG gel appears to be effective against gingivitis in the periodontal pocket through its increased anti-inflammatory activity and the crosslinking of genipin with the biological tissue.


Asunto(s)
Iridoides/uso terapéutico , Ketorolaco Trometamina/uso terapéutico , Enfermedades Periodontales/tratamiento farmacológico , Adhesivos Tisulares/uso terapéutico , Adulto , Animales , Cromatografía Líquida de Alta Presión , Método Doble Ciego , Combinación de Medicamentos , Composición de Medicamentos , Femenino , Geles , Humanos , Técnicas In Vitro , Glicósidos Iridoides , Iridoides/administración & dosificación , Iridoides/química , Iridoides/farmacocinética , Ketorolaco Trometamina/administración & dosificación , Ketorolaco Trometamina/química , Ketorolaco Trometamina/farmacocinética , Masculino , Ratones , Ratones Pelados , Persona de Mediana Edad , Enfermedades Periodontales/metabolismo , Absorción Cutánea/efectos de los fármacos , Resistencia a la Tracción , Adhesivos Tisulares/administración & dosificación , Adhesivos Tisulares/química , Adhesivos Tisulares/farmacocinética
10.
J Pharm Pharm Sci ; 10(1): 1-8, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17498388

RESUMEN

PURPOSE: Low-frequency ultrasound has a significant effect on the transdermal permeation of high molecular weight drugs. However, the rate of permeation in pulsed mode is quite low necessitating considerable time to apply the ultrasound. 0.5 MHz ultrasound, which is a relatively higher frequency in the low-frequency range, can be applied in high intensity in continuous mode. METHODS: A transducer was used to administer an anesthetic drug transdermally on healthy volunteers. The anesthetic effect was measured following administration on placebo, lidocaine HCl alone and lidocaine HCl with 0.5 and 1.0 MHz ultrasound (n=8/group). RESULTS: In surface anesthesia, the phonophoresis group showed a significantly higher pain threshold than the other groups but there was no significant difference between the phonophoresis groups according to the ultrasound frequency. In conduction anesthesia, the 0.5 MHz phonophoresis group showed a significant change in their pain threshold and amplitude of sensory nerve action potential (SNAP) compared with the other groups. CONCLUSIONS: Although there are limitations in applying 0.5 MHz ultrasound in phonophoresis for conduction anesthesia using lidocaine hydrochloride for a nerve block, it is more effective than the 1 Mhz that is widely used in clinical situations. Carbamazepine is a poor water soluble drug and its bioavailability is limited by dissolution rate. Dissolution, serum concentration and anticonvulsive effect of the drug have been evaluated after cogrinding with microcrystalline cellulose. A cogrinding technique was used to increase the dissolution, serum concentrations and anticonvulsive effect of the drug. A novel deconvolution technique of in vitro-in vivo correlation was evaluated.


Asunto(s)
Anestésicos Locales/administración & dosificación , Lidocaína/administración & dosificación , Fonoforesis , Administración Cutánea , Anestésicos Locales/farmacología , Geles , Humanos , Lidocaína/farmacología , Masculino , Umbral del Dolor/efectos de los fármacos , Ultrasonido
11.
Arch Pharm Res ; 29(5): 412-7, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16756087

RESUMEN

Triamcinolone acetonide (TA) is a corticosteroid that is used in the systemic and topical treatment of many inflammatory diseases. In this study, a phonophoretic drug delivery system was designed to enhance the TA permeability and the influence of ultrasound was examined. In order to establish the transdermal delivery system for TA, a hydrophilic carbopol gel containing TA was prepared after adopting phonophoresis. A permeation study through mouse skin was performed at 37 degrees C using a Franz diffusion cell, and the ultrasound treatment was carried out for 10 h. The level of TA permeation through the skin was evaluated under various ultrasound conditions including the frequency (1.0, 3.0 MHz), intensity (1.0, 2.5 W/cm2), and duty cycle (continuous, pulse mode) using a 0.5% TA gel. The highest permeation was observed under the ultrasound treatment conditions of low frequency, high intensity, and in continuous mode.


Asunto(s)
Antiinflamatorios/administración & dosificación , Sistemas de Liberación de Medicamentos , Fonoforesis/métodos , Piel/metabolismo , Triamcinolona Acetonida/administración & dosificación , Administración Cutánea , Animales , Antiinflamatorios/farmacocinética , Geles , Técnicas In Vitro , Masculino , Ratones , Ratones Pelados , Permeabilidad , Piel/química , Absorción Cutánea , Solubilidad , Temperatura , Triamcinolona Acetonida/farmacocinética
12.
Int J Pharm ; 302(1-2): 39-46, 2005 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-16098696

RESUMEN

The present study was carried out to determine the feasibility of using gel formulations for the transdermal delivery of triamcinolone acetonide (TA), which is one of the synthetic glucocorticoids, in conjunction with phonophoresis, and to develop the carbopol gels of TA. For this purpose, the anti-inflammatory effects of the gel containing TA after the adoption of ultrasound were evaluated by investigating the in vivo change in the serum creatine phosphokinase (CPK) and histological findings. Following a muscle injury, the serum CPK activity decreased significantly in the TA gel group with phonophoresis, comparing with that in the control group and the commercial gel group given ultrasound. In the gross finding, after a muscle injury, the TA gel group with phonophoresis showed rapid moderation of the injury compared with the three other groups. The histological findings showed that the inflammation was relieved within 72 h after the injury from the TA gel group with phonophoresis. These effects were considerably higher in the phonophoresis group than in the other three groups. Overall, a TA gel using phonophoresis might be used as a new transdermal delivery technique providing enhanced anti-inflammatory effects.


Asunto(s)
Antiinflamatorios/farmacología , Fonoforesis/métodos , Triamcinolona Acetonida/farmacología , Administración Cutánea , Análisis de Varianza , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacocinética , Creatina Quinasa/sangre , Geles , Masculino , Músculos/irrigación sanguínea , Músculos/efectos de los fármacos , Músculos/lesiones , Ratas , Ratas Sprague-Dawley , Piel/irrigación sanguínea , Piel/efectos de los fármacos , Piel/lesiones , Absorción Cutánea , Triamcinolona Acetonida/administración & dosificación , Triamcinolona Acetonida/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...